SCHEMBL541285

SCHEMBL541285

FC1(F)C[N]CC1(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL896136 0.84
SCHEMBL78899 0.76
SCHEMBL3458517 0.67
SCHEMBL895771 0.62
SCHEMBL1897021 0.57
SCHEMBL6306884 0.53
SCHEMBL726127 0.53
SCHEMBL321149 0.52
SCHEMBL4131162 0.48
SCHEMBL63852 0.48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513808-A2 FLUORINATED CYCLIC AMIDES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS Pfizer Products Inc. (US) 2005-03-16 EP claimed
WO-2005019168-A2 FLUORINATED LYSINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS PFIZER PRODUCTS INC. (US) 2005-03-03 WO claimed
US-20050043292-A1 Fluorinated lysine derivatives as dipeptidyl peptidase IV inhibitors PFIZER INC 2005-02-24 US claimed
US-20040132713-A1 Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors PFIZER INC 2004-07-08 US claimed
US-6710040-B1 Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors PFIZER INC. 2004-03-23 US claimed
WO-2003101958-A2 FLOURINATED CYCLIC AMIDES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS PFIZER PRODUCTS INC. (US) 2003-12-11 WO claimed
WO-2024091409-A1 TRICYCLIC DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-05-02 WO disclosed
WO-2024054625-A2 BIFUNCTIONAL COMPOUNDS FOR DEGRADING KRAS G12D VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2024-03-14 WO disclosed
US-20230391721-A1 ANTICANCER COMPOUNDS SELECTIVE FOR ER-POSITIVE CANCERS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2023-12-07 US disclosed
US-20230357210-A1 NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUND HAVING AN OXIME GROUP, AGRICULTURAL OR HORTICULTURAL HERBICIDE COMPRISING THE COMPOUND, AND METHOD FOR USING THE COMPOUND OR THE HERBICIDE NIHON NOHYAKU CO., LTD. (JP) 2023-11-09 US disclosed
US-20230339937-A1 CONDENSED RING COMPOUNDS THAT INHIBIT H-PGDS SATO PHARMACEUTICAL CO., LTD. (JP) 2023-10-26 US disclosed
EP-4232038-A1 ANTICANCER COMPOUNDS SELECTIVE FOR ER-POSITIVE CANCERS The Board of Trustees of the University of Illinois (US) 2023-08-30 EP disclosed
WO-2023113023-A1 AZAINDOLE DERIVATIVE INHIBITING H-PGDS 佐藤製薬株式会社 2023-06-22 WO disclosed
US-20070072908-A1 Heterocyclic compounds JAPAN TOBACCO INC. (JP) 2007-03-29 US disclosed
EP-1513808-A2 FLUORINATED CYCLIC AMIDES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS Pfizer Products Inc. (US) 2005-03-16 EP disclosed
WO-2005019168-A2 FLUORINATED LYSINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS PFIZER PRODUCTS INC. (US) 2005-03-03 WO disclosed
US-20050043292-A1 Fluorinated lysine derivatives as dipeptidyl peptidase IV inhibitors PFIZER INC 2005-02-24 US disclosed
US-20040132713-A1 Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors PFIZER INC 2004-07-08 US disclosed
US-6710040-B1 Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors PFIZER INC. 2004-03-23 US disclosed
WO-2003101958-A2 FLOURINATED CYCLIC AMIDES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS PFIZER PRODUCTS INC. (US) 2003-12-11 WO disclosed